197 related articles for article (PubMed ID: 27759912)
21. A Rare Case of Familial Schwannomatosis Showing Intrafamilial Variability with Identification of a Shared Novel Germline
Lee JH; Jeong JS; Chae KJ; Han YH; Kim SR; Lee YC
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363549
[TBL] [Abstract][Full Text] [Related]
22. What to know about schwannomatosis: a literature review.
Schraepen C; Donkersloot P; Duyvendak W; Plazier M; Put E; Roosen G; Vanvolsem S; Wissels M; Bamps S
Br J Neurosurg; 2022 Apr; 36(2):171-174. PubMed ID: 33263426
[TBL] [Abstract][Full Text] [Related]
23. Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis.
Smith MJ; Wallace AJ; Bowers NL; Rustad CF; Woods CG; Leschziner GD; Ferner RE; Evans DG
Neurogenetics; 2012 May; 13(2):141-5. PubMed ID: 22434358
[TBL] [Abstract][Full Text] [Related]
24. SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis.
Rousseau G; Noguchi T; Bourdon V; Sobol H; Olschwang S
BMC Neurol; 2011 Jan; 11():9. PubMed ID: 21255467
[TBL] [Abstract][Full Text] [Related]
25. Expanding the mutational spectrum of LZTR1 in schwannomatosis.
Paganini I; Chang VY; Capone GL; Vitte J; Benelli M; Barbetti L; Sestini R; Trevisson E; Hulsebos TJ; Giovannini M; Nelson SF; Papi L
Eur J Hum Genet; 2015 Jul; 23(7):963-8. PubMed ID: 25335493
[TBL] [Abstract][Full Text] [Related]
26. Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.
Plotkin SR; Blakeley JO; Evans DG; Hanemann CO; Hulsebos TJ; Hunter-Schaedle K; Kalpana GV; Korf B; Messiaen L; Papi L; Ratner N; Sherman LS; Smith MJ; Stemmer-Rachamimov AO; Vitte J; Giovannini M
Am J Med Genet A; 2013 Mar; 161A(3):405-16. PubMed ID: 23401320
[TBL] [Abstract][Full Text] [Related]
27. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
28. Broadening the spectrum of SMARCB1-associated malignant tumors: a case of uterine leiomyosarcoma in a patient with schwannomatosis.
Paganini I; Sestini R; Cacciatore M; Capone GL; Candita L; Paolello C; Sbaraglia M; Dei Tos AP; Rossi S; Papi L
Hum Pathol; 2015 Aug; 46(8):1226-31. PubMed ID: 26001331
[TBL] [Abstract][Full Text] [Related]
29. A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis.
Zhang K; Lin JW; Wang J; Wu X; Gao H; Hsieh YC; Hwu P; Liu YR; Su L; Chiou HY; Wang D; Yuan YC; Whang-Peng J; Chiu WT; Yen Y
Genet Med; 2014 Oct; 16(10):787-92. PubMed ID: 24763291
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the frequency of loss-of-function LZTR1 variants between schwannomatosis patients and the general population.
Deng F; Evans DG; Smith MJ
Hum Mutat; 2022 Jul; 43(7):919-927. PubMed ID: 35391499
[TBL] [Abstract][Full Text] [Related]
31. SMARCB1 involvement in the development of leiomyoma in a patient with schwannomatosis.
Hulsebos TJ; Kenter S; Siebers-Renelt U; Hans V; Wesseling P; Flucke U
Am J Surg Pathol; 2014 Mar; 38(3):421-5. PubMed ID: 24525513
[TBL] [Abstract][Full Text] [Related]
32. ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis.
Evans DG; Mostaccioli S; Pang D; Fadzil O Connor M; Pittara M; Champollion N; Wolkenstein P; Thomas N; Ferner RE; Kalamarides M; Peyre M; Papi L; Legius E; Becerra JL; King A; Duff C; Stivaros S; Blanco I
Eur J Hum Genet; 2022 Jul; 30(7):812-817. PubMed ID: 35361920
[TBL] [Abstract][Full Text] [Related]
33. RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas.
Melean G; Velasco A; Hernández-Imaz E; Rodríguez-Álvarez FJ; Martín Y; Valero A; Hernández-Chico C
Neurogenetics; 2012 Aug; 13(3):267-74. PubMed ID: 22752724
[TBL] [Abstract][Full Text] [Related]
34. Segmental schwannomatosis: characteristics in 12 patients.
Alaidarous A; Parfait B; Ferkal S; Cohen J; Wolkenstein P; Mazereeuw-Hautier J
Orphanet J Rare Dis; 2019 Aug; 14(1):207. PubMed ID: 31438995
[TBL] [Abstract][Full Text] [Related]
35. Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis.
Smith MJ; Bowers NL; Bulman M; Gokhale C; Wallace AJ; King AT; Lloyd SK; Rutherford SA; Hammerbeck-Ward CL; Freeman SR; Evans DG
Neurology; 2017 Jan; 88(1):87-92. PubMed ID: 27856782
[TBL] [Abstract][Full Text] [Related]
36. Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes.
Perez-Becerril C; Evans DG; Smith MJ
Hum Mutat; 2021 Oct; 42(10):1187-1207. PubMed ID: 34273915
[TBL] [Abstract][Full Text] [Related]
37. LZTR1-related spinal schwannomatosis and 7q11.23 duplication syndrome: A complex phenotype with dual diagnosis.
Muthusamy K; Mrugala MM; Bendok BR; Dhamija R
Mol Genet Genomic Med; 2021 Jan; 9(1):e1560. PubMed ID: 33269527
[TBL] [Abstract][Full Text] [Related]
38. Neurofibromas in LZTR1 schwannomatosis.
Groen JL; Moghadasi S; Spruijt L; Korpershoek E; van Ierland Y; van Wezel JT; van Duinen S; Malessy MJA; Lesnik Oberstein SAJ
Clin Genet; 2022 May; 101(5-6):571-572. PubMed ID: 35178712
[No Abstract] [Full Text] [Related]
39. Hereditary intraspinal schwannomatosis with SMARCB1 gene mutation: A case report.
Li Y; Chen L; Shao D; Zhang B; Xie S; Zheng X; Jiang Z
J Clin Lab Anal; 2022 Jun; 36(6):e24448. PubMed ID: 35446994
[TBL] [Abstract][Full Text] [Related]
40. [Segmental schwannomatosis in upper-extremity: 5 cases report and literature review].
Wang ZX; Chen SL; Yi CJ; Li C; Rong YB; Tian GL
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):698-703. PubMed ID: 24136261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]